NIH-funded research R01 grant

MOF’s role in weakening the aorta and stopping aneurysm growth

Official title: MOF Regulates Abdominal Aortic Aneurysm Expansion

Funded at University of Michigan at Ann Arbor · NIH-11424572 · Data updated 2026-11-12

Scientists are studying how a molecule called MOF and inflammatory signals affect abdominal aortic aneurysms to find ways to slow or stop their enlargement.

More Aneurysm research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startSeptember 5, 2026
Project endApril 30, 2031
Funding year2026
Award (this year)$785,185
NIH project number1R01HL187297-01
Project IDNIH-11424572 on NIH RePORTER

Who could benefit from this research

Could help

Adults with abdominal aortic aneurysm or at risk due to inflammatory vascular processes; subjects contributing human tissue or cells for analysis.

Less likely to help

No direct patient benefit if you do not have an abdominal aortic aneurysm or related inflammatory vascular condition.

What this research studies

This project uses human cells and mouse models to explore how MOF, a protein that changes how genes are turned on, contributes to the inflammation and growth of abdominal aortic aneurysms. The team examines how TNF-α signaling leads to MOF activity in macrophages within the aorta, and how this drives inflammatory gene programs linked to aneurysm expansion. They will test whether blocking MOF-related changes in monocytes and macrophages can reduce inflammation and stabilize the aneurysm in experimental settings. By combining human tissue data with animal models, the research aims to uncover targets that could translate into therapies to limit aneurysm growth.

Why it matters

Potential benefit: If successful, the work could lead to new strategies to prevent aneurysm growth and reduce the risk of rupture.

How similar studies have gone: Prior studies have linked inflammatory macrophages and epigenetic regulators to aneurysm biology, suggesting this approach could yield actionable targets, though the exact MOF/TNF-α pathway in humans requires validation.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Davis, Frank Michael — University of Michigan at Ann Arbor
  • Study coordinator: Davis, Frank Michael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.